1 European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Recommendations on Treatment of Hepatitis C 2018. J Hepatol. 2018. doi: 10.1016/j.jhep.2018.03.026. PubMed PMID: 29650333.
2 Chou R, Wasson N. Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Ann Intern Med. 2013;159(5):372. doi: 10.7326/0003-4819-159-5-201309030-00021. PubMed PMID: 24026329.
3 Mullhaupt B, Fehr J, Moradpour D, Rauch A. Treatment of Chronic Hepatitis C – August 2018 Update SASL-SSI Expert Opinion Statement. 2018.
4 Richard JL, Schaetti C, Basler S, Mausezahl M. The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988–2015. Swiss Med Wkly. 2018;148:w14619. doi: 10.4414/smw.2018.14619. PubMed PMID: 29698546.
5 Fretz R, Negro F, Bruggmann P, Lavanchy D, De GA, Pache I, Masserey S, V, Cerny A. Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss Med Wkly. 2013;143:w13793. doi: 10.4414/smw.2013.13793 [doi];smw-13793 [pii].
6 Bruggmann P, Negro F, Bihl F, Blach S, Lavanchy D, Mullhaupt B, Razavi H, Semela D. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland. Swiss Med Wkly. 2015;145:w14221. doi: 10.4414/smw.2015.14221 [doi];smw-14221 [pii].
7 Bertisch B, Giudici F, Negro F, Moradpour D, Mullhaupt B, Moriggia A, Estill J, Keiser O, Swiss Hepatitis CCS. Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations. PLoS One. 2016;11(5):e0155464. doi: 10.1371/journal.pone.0155464. PubMed PMID: 27227332; PMCID: PMC4882055.